Emergent Findings With Potentially High Impact
Submissions in this category should highlight novel, unanticipated, high-impact or disruptive studies, with a time-sensitive urgency, to present at ASM Microbe. Such findings should have clear public impact and/or advance a field significantly or in new directions.
Examples in this category include work related to a new outbreak or research describing a newly uncovered biological mechanism.
https://www.abstractsonline.com/dashboard/login.asp?aId=1&targetMKey=%7bFC0AD65D-4E42-4CDC-99D3-EB6F36A74C15%7d&targetMod=submit
Important note: This is not an opportunity to submit an abstract that only describes a rigorous study that could have been submitted during the general submission periods. General submission abstracts will be rejected if submitted in the emergent findings category.
Questions? Contact the ASM Microbe Programming Team.
Important Dates
Second Round Abstract Dispositions Sent: March 31, 2022.
Emerging Science Abstracts Open: April 5, 2022, 12 p.m. EDT.
Emerging Science Abstracts Close: April 20, 2022, 12 p.m. EDT.
What You Need to Know Before Submitting Your Abstract
- Abstract Title: Please use a short and concise title that indicates the content of the abstract. (Please note: The title is not included in the total character count of 2200).
- Abstract Body Text: Your abstract may have up to 2200 characters, which does not include title, authors, groups, and affiliations.
- Tables and graphics (maximum of 500 characters) are included in the character count.
- Spaces are not counted. Do NOT include abstract title, authors or keywords in abstract text.
- Abstract text may be submitted using the following methods: Either copy/paste, direct entry keystrokes, or file upload.
- Your abstract may be written without the use of the following bolded headers (e.g., background, methods, results, conclusion).
- Follow the abstract guidelines to ensure all required information about your study is provided in your abstract.
- Author(s) Information: Author(s)’s name(s), institution(s), location(s), title(s).
- CE Disclosures: Relative to this activity, instructors, planners, content reviewers and managers who affect the content of a CME/CE activity are required to disclose relevant financial relationships they have with commercial interests (i.e., any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients).
For more detailed information and step-by-step instructions on how to submit your abstract for ASM Microbe 2022, please visit the abstract submission site.
Technical Support
If you have any questions regarding use of the abstract submission site, please contact technical support at asm@support.ctimeetingtech.com.
Have additional questions? View our FAQs.
https://asm.org/Events/ASM-Microbe/Abstracts/Abstract-Embargo-Policy
General Abstract Guidelines
All Submitted Abstracts
- It is preferred that ASM Microbe 2022 be the first major presentation of the abstract.
- A presenter may be a presenter on more than one abstract.
- Programming decisions are considered final.
- Abstracts must be well written and easy to understand.
- Approval of all co-authors must be obtained before placing their names on an abstract.
- Submission of multiple overlapping abstracts is discouraged.
Clinical Tracks (AAR, CPHM, CIV, POM)
- The reason for the study, or how the study came about, (e.g. hypothesis, discovery or central question) should be clearly stated.
- Methods must be included.
- Data must be objectively gathered, analyzed and reported.
- Data must support the stated conclusion(s).
- All presentations dealing with the isolation, purification, structure-activity relationships, mechanisms of action, in vivo/in vitro microbiology, PK/PD in animals and Pre-US IND or non-US early phase I studies must include meaningful data (e.g., producing organism, purification steps, physical-chemical characterization, structures, MICs, ED50s to describe new compounds and their properties, and that chemical structures of lead compounds will be included as part of the poster presentation).
- Please note: Any posters or talks dealing with a specific small molecule antimicrobial agent must provide a chemical structure, or a literature reference to the structure, in order to be presented at the meeting. Abstracts describing biological data on an antimicrobial agent whose chemical structure has not been defined should be submitted to the HMB track.
- Scientific presentations at ASM Microbe 2022 will be expected to transparently report a study’s scientific rigor, including but, not limited to the following: 1) experimental design; 2) methodology; 3) data collection; 4) analysis and 5) interpretation and report of results. Other key components of scientific rigor included, if applicable, are sample size, randomization, blinding, and replication.
Basic Science Tracks (AES, EEB, HMB, MBP)
- The reason for the study or how the study came about, (e.g. hypothesis, discovery or central question) should be clearly stated.
- Data must be objectively gathered, analyzed and reported.
- Data must support the stated conclusion(s).
- Conclusion(s) should be made but, the study does not need to be fully complete (the standard to present at Microbe is not the same as to publish in a journal).
- Abstracts describing biological data on an antimicrobial agent whose chemical structure has not been defined should be submitted to the HMB track.
- Scientific presentations at ASM Microbe 2022 will be expected to transparently report a study’s scientific rigor, including, but not limited to the following: 1) experimental design and 2) interpretation and report of results.